Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 27, 2018Pediatric Blood & Cancer

Late effects in high‐risk neuroblastoma survivors treated with high‐dose chemotherapy and stem cell rescue

View Full Paper
Ask AI
Bookmark
Share

Authors

MEMahmoud M. ElzembelyAssiut UniversityADAnn DahlbergSeattle Children's HospitalNPNavin PintoSeattle Children's Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Elzembely et al. (2018) studied this question.

synapsesocial.com/papers/6a01bc47950a93c470d8b541https://doi.org/10.1002/pbc.27421
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report2008 · 1,176 citations
  2. 2Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline2004 · 715 citations
  3. 3Cisplatin and Aminoglycoside Antibiotics: Hearing Loss and Its Prevention2012 · 352 citations
  4. 4Ototoxicity following pediatric hematopoietic stem cell transplantation: A prospective cohort study2004 · 43 citations
  5. 5Approach for Classification and Severity Grading of Long-term and Late-Onset Health Events among Childhood Cancer Survivors in the St. Jude Lifetime Cohort2016 · 229 citations